discogenic cells
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 26, 2018 (NCT03347708)
Timeline
Indications
Mechanism of action
- BoneTissue restoration
Bone tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07254806 | Phase 3 | Nov 24, 2025 | DiscGenics, Inc. |
| NCT03955315 | Phase 1/Phase 2 (Phase 2) | May 23, 2019 | DiscGenics, Inc. |
| NCT03347708 | Phase 1/Phase 2 (Phase 2) | Feb 26, 2018 | DiscGenics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DiscGenics, Inc. | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1